Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone Palmitate
This study is currently recruiting participants.
Verified October 2013
by Janssen-Cilag Farmaceutica Ltda.
Study NCT01448720 Information provided by Janssen-Cilag Farmaceutica Ltda.
First Received on September 6, 2011. Last Updated on October 4, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Central Nervous System Agents
Central Nervous System Depressants
Physiological Effects of Drugs
Sponsors listed in this trial
Janssen-Cilag Farmaceutica Ltda.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers